DOI: 10.36347/sjams.2013.v01i06.0031

Pages: 789-792

Type-2 diabetic is increased manifold in recent years and India is very well considered as the diabetic capital of the world. Diabetes poses a great economic burden to the family and the nation. FBS and PPBS has always been the test of choice for diagnosis of diabetes though OGTT is considered often. But the trend of using HbA1c for diagnosis is not there in India although HbA1c is very often used for monitoring of diabetes. The stringent requirements for FBS, PPBS and OGTT assay reduce its compliance among the patients, besides these tests are not free from fallacies. With the recommendation of HbA1c for diagnosis of diabetes by ADA we feel HbA1c can be instrumental in the diagnosis of type-2 diabetes India. Though the cost incurred is more, yet the easy compliance due to lack of stringent requirements and accuracy of results by standardized methods, HbA1c can be the one test diagnostic method for a country like India. Though the matter is open to debate we conclude the HbA1c can be used for diagnosis of diabetes in India.